“…For instance, for LCNPs serving as drug delivery vehicles, adsorption of material to the storage container, catheters and other delivery devices must be minimized, while systems designed for surface modifying applications would require maximal adsorption. Studies of the interaction of different LCNPs with supported model lipid membranes 4,7,9,11,12 , vesicles 2 and blood 2,13,14 have helped to explain the characteristic interactions of the particles with biological interfaces and components. We have previously studied the interaction of both SPC/GDO 7,9 and GMO 11,15 based LCNPs with silicon surfaces, either in the natural hydrophilic state or rendered hydrophobic or cationic.…”